Article
[Revolution in the treatment of cystic fibrosis].
Revue medicale suisse - 17 Jun 2020
Sauty Alain, Plojoux Jérôme, Mornand Anne, Blanchon Sylvain, Koutsokera Angela
Abstract excerpt
Cystic Fibrosis is a genetic disorder resulting in the absence or dysfunction of the CFTR protein, a chloride channel present on the surface of epithelia, particularly respiratory. Until recently, treatments only concerned the consequences of the disease. But a new type of molecules called « modulators », is already available to some patients and targets the origin of the disease. « Modulators » are divided into...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
